InsiderTrades

Form 4 for NVDA Nvidia

Accepted 2022-03-02 18:58:11 ET · period of report 2022-03-01 · accession 0001045810-22-000010 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-03-02 18:58 2022-03-01 NVDA HUANG JEN HSUN Pres, CEO, Dir M - OptEx $3.62 +292.3K 5.47M +6% +$1.06M
DM 2022-03-02 18:58 2022-03-01 NVDA HUANG JEN HSUN Pres, CEO, Dir S - Sale+OE $237.12 -292.3K 5.18M -5% -$69.32M
D 2022-03-02 18:58 2022-03-01 NVDA HUANG JEN HSUN Pres, CEO, Dir M - OptEx $0.00 -292.3K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-03-01 M A 292,340 $3.62 5,471,307 D — — (F1) This transaction was pursuant to a 10b5-1 Plan. (F2) Includes 42 shares purchased pursuant to the Issuer's Employee Stock Purchase Plan on February 28, 2022.
2 Common Common Stock 2022-03-01 S D 27,280 $232.03 5,444,027 D — — (F1) This transaction was pursuant to a 10b5-1 Plan. (F3) Represents weighted average sales price. The shares were sold at prices ranging from $231.42 to $232.41. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
3 Common Common Stock 2022-03-01 S D 34,353 $232.88 5,409,674 D — — (F1) This transaction was pursuant to a 10b5-1 Plan. (F4) Represents weighted average sales price. The shares were sold at prices ranging from $232.42 to $233.41. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
4 Common Common Stock 2022-03-01 S D 41,983 $233.93 5,367,691 D — — (F1) This transaction was pursuant to a 10b5-1 Plan. (F5) Represents weighted average sales price. The shares were sold at prices ranging from $233.42 to $234.41. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
5 Common Common Stock 2022-03-01 S D 29,661 $234.87 5,338,030 D — — (F1) This transaction was pursuant to a 10b5-1 Plan. (F6) Represents weighted average sales price. The shares were sold at prices ranging from $234.42 to $235.41. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
6 Common Common Stock 2022-03-01 S D 21,446 $235.89 5,316,584 D — — (F1) This transaction was pursuant to a 10b5-1 Plan. (F7) Represents weighted average sales price. The shares were sold at prices ranging from $235.42 to $236.38. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
7 Common Common Stock 2022-03-01 S D 2,000 $236.82 5,314,584 D — — (F1) This transaction was pursuant to a 10b5-1 Plan. (F8) Represents weighted average sales price. The shares were sold at prices ranging from $236.42 to $237.39. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
8 Common Common Stock 2022-03-01 S D 5,700 $238.19 5,308,884 D — — (F1) This transaction was pursuant to a 10b5-1 Plan. (F9) Represents weighted average sales price. The shares were sold at prices ranging from $237.50 to $238.49. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
9 Common Common Stock 2022-03-01 S D 24,525 $239.12 5,284,359 D — — (F1) This transaction was pursuant to a 10b5-1 Plan. (F10) Represents weighted average sales price. The shares were sold at prices ranging from $238.51 to $239.50. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
10 Common Common Stock 2022-03-01 S D 19,803 $239.82 5,264,556 D — — (F1) This transaction was pursuant to a 10b5-1 Plan. (F11) Represents weighted average sales price. The shares were sold at prices ranging from $239.51 to $240.49. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
11 Common Common Stock 2022-03-01 S D 21,398 $241.04 5,243,158 D — — (F1) This transaction was pursuant to a 10b5-1 Plan. (F12) Represents weighted average sales price. The shares were sold at prices ranging from $240.52 to $241.51. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
12 Common Common Stock 2022-03-01 S D 52,983 $241.96 5,190,175 D — — (F1) This transaction was pursuant to a 10b5-1 Plan. (F13) Represents weighted average sales price. The shares were sold at prices ranging from $241.54 to $242.49. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
13 Common Common Stock 2022-03-01 S D 11,208 $242.88 5,178,967 D — — (F1) This transaction was pursuant to a 10b5-1 Plan. (F14) Represents weighted average sales price. The shares were sold at prices ranging from $242.55 to $243.33. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
14 Derivative Employee Stock Option (Right to Buy) 2022-03-01 M D 292,340 $0.00 0 D $3.62 · — to 2022-03-20 292,340 Common Stock (F1) This transaction was pursuant to a 10b5-1 Plan. (F19) Fully vested.